Zydus Lifesciences Limited is involved in the exploration, development, manufacturing, promotion, distribution, and trade of pharmaceutical products on a global scale, with operations spanning India, the United States, and other international markets. The company operates through two main segments, namely Pharmaceuticals and Consumer Products. Its product portfolio includes a range of finished dosage human formulations, such as generics, branded generics, specialty formulations (including biosimilars and vaccines), active pharmaceutical ingredients, and consumer wellness products. These offerings cover therapeutic areas like pain management, neurology, metabolic disorders, and liver diseases. Zydus Lifesciences Limited markets its products under well-known brands like Everyuth, Nutralite, Complan, Glucon D, and Nycil.
Moreover, the company is actively involved in developing a pipeline of biological products, focusing on areas such as oncology, autoimmune diseases, nephrology, inflammation, rheumatology, hepatology, and infectious illnesses. Apart from its core pharmaceutical business, Zydus Lifesciences Limited also participates in various activities like investment, animal health and veterinary services, pharmacy retail, and manpower supply and administration.
Originally known as Cadila Healthcare Limited, the company underwent a name change to Zydus Lifesciences Limited in February 2022. Established in 1952, Zydus Lifesciences Limited is headquartered in Ahmedabad, India.